Unlock instant, AI-driven research and patent intelligence for your innovation.

or2w3 gene mutant and its application

A technology for amino acids and degenerative diseases, which is applied in the fields of application, genetic engineering, and plant genetic improvement, and can solve problems that need to be further studied

Inactive Publication Date: 2017-03-01
ARMY MEDICAL UNIV +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the current research on retinitis pigmentosa still needs to be in-depth

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • or2w3 gene mutant and its application
  • or2w3 gene mutant and its application
  • or2w3 gene mutant and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Example 1 Mutation screening of known sites

[0063] In order to find the causative mutation gene and exclude known genes, the inventors conducted mutation screening on the affected members of the family. In RP patients (II-1) and healthy controls (II-8), peripheral venous blood was collected, and DNA was extracted from peripheral granulocytes using the TIANamp blood DNA extraction kit. The exons of the gene and the splice sites of the flanking introns were sequenced and further confirmed by Sanger sequencing. Previous research results have shown that the genes related to RP are: RP1, RPGR, RP2, RHO, PRPH2, ROM1 / PRPH2, RP9, IMPDH1, PRPF31, CRB1, PRPF8, TULP1, CA4, PRPF3, ABCA4, RPE65, EYS, CERKL , NRL, FAM161A, FSCN2, TOPORS, SNRNP200, SEMA4A, PRCD, NR2E3, MERTK, USH2A, PDE6B, PROM1, KLHL7, PDE6A, RGR, CNGB1, IDH3B, SAG, GUCA1B, CNGA1, BEST1, TTC8, RDH12, C2orf71, ARL6 , IMPG2, PDE6G, ZNF513, DHDDS, PRPF6, CLRN1, MAK, CDHR1, RBP3, RPGR, CC2D2A, FLVCR1, TTPA, OFD1, RLB...

Embodiment 2

[0064] Example 2 Using Whole Exome Sequencing to Identify Pathogenic Genes

[0065] Select 5 members of the family, including 4 RP patients (II-2, II-3, II-4, II-7) and 1 normal member (II-9). 30 μg of human genomic DNA was extracted from the peripheral venous blood of each participant, and used for subsequent experiments after passing the test. According to the operating instructions of the Covaris Acoustic system, the genomic DNA was broken into random fragments, and then the fragments were ligated using adapters to prepare a hybrid library. Human genomic DNA was subjected to ligation-mediated PCR (LM-PCR) amplification, purification, and Nimblegen SeqCap EZ laboratory v3.0 (Roche / NimbleGen, Madison, WI) hybridization enhancement, LM-PCR capture and uncaptured product utilization The degree of enhancement was assessed by Q-PCR. Each captured library was loaded on a Hiseq2500 plate (Illumina, San Diego, CA), and high-throughput sequencing of each captured gene library was p...

Embodiment 3d

[0077] Example 3 Sanger sequencing verification of de novo SNP sites in the family and in the normal population control group

[0078] To determine whether any remaining variants in this family cosegregated with the disease phenotype, the inventors performed Sanger sequencing on DNA samples from other members of the family to confirm the mutation. The direct PCR product was sequenced with ABI3730 Genetic Analyzer, and the obtained data was compared with the human genome database (GRCh37, UCSChg19) to detect mutations. The possible pathogenic mutations were further verified using the RP family tree database of Shenzhen Huada Gene Research Institute, which contains the whole exome sequence data of several RP families.

[0079] Using the peripheral venule blood of each participant as a sample, 30 μg of human genomic DNA was extracted using the TIANamp Blood DNA Extraction Kit, which was used for subsequent experiments after passing the test.

[0080] PCR reaction primer design r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an isolated nucleic acid for coding an OR2W3 mutant, an isolated polypeptide, a method for screening biological samples vulnerable to retinitis pigmentosa diseases, a system for screening biological samples vulnerable to retinitis pigmentosa diseases, a kit used for screening samples vulnerable to retinitis pigmentosa diseases, and a method for screening drugs for treating or preventing retinitis pigmentosa diseases. Compared with SEQ ID NO.1, the isolated nucleic acid for coding the OR2W3 mutant has c.C424T mutation. Whether the biological samples are vulnerable to retinitis pigmentosa diseases can be effectively detected by detecting whether the new mutant exists in the biological samples.

Description

technical field [0001] The present invention relates to OR2W3 gene mutant and its application. Specifically, the present invention relates to an isolated nucleic acid encoding an OR2W3 mutant, an isolated polypeptide, a method for screening a biological sample susceptible to a retinitis pigmentosa disease, a system for screening a biological sample susceptible to a retinitis pigmentosa disease, and a system for screening a susceptible A reagent kit for biological samples of retinitis pigmentosa and a method for screening drugs for treating or preventing retinitis pigmentosa. Background technique [0002] Retinitis pigmentosa (RP, MIM#268000) is a heterogeneous hereditary eye disease. According to the survey data in my country, the prevalence rate of this disease reaches 1 / 3000-1 / 5000. Clinically, this disease is a hereditary eye disease characterized by progressive vision loss, night blindness, narrowed vision and retinal pigmentation, which may eventually cause severe visi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/12C07K14/47C12M1/34C12Q1/68C12Q1/02
Inventor 马翔宇李亚斐管李萍张耀许斌沈苗忠陈演华王阅雯尹烨李英睿徐讯
Owner ARMY MEDICAL UNIV